Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Votrient in Advanced Breast Cancer
NCT01466972Phase 2Completed
- Sponsor
- Hope Rugo
- Start
- Apr 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in breast cancer, sponsored by Hope Rugo. Started Apr 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01466972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466972.